Release source: Release date:July 8, 2020

Effepharm started our new clinical trials on UtheverTM NMN ingredient recently. According to ICTRP ( International Clinical Trials Registry Platform),  the clinical trial on UtheverTM is the largest scale trial on NMN in the world. What’s more, Effepham is the first and the only NMN ingredient manufacturer to conduct clinical trials in the world. And we will stand the test of time and become the golden standard of NMN. It’s our duty to assure the quality of UtheverTM and protect people from inferior NMN raw material.

We have conducted lots of animal studies on UtheverTM previously and some projects are still ongoing. Meanwhile, we use the most objective method, A multicenter, randomized, double-blind, parallel design, placebo-controlled study to evaluate the efficacy and safety of UtheverTM. It is widely used and accepted by pharmaceutical R&D. Effepharm is trying to let the public know what they do, how they do and why they do.

We are not only a professional NMN R&D center but also an information center. The public can get scientific knowledge about NMN and other dietary ingredients. Through our endeavors, more and more people will know UtheverTM and benefit from UtheverTM.

IDS(Ingredient Delivery System) is Effepharm’s unique application platform to solve problems like dissolution, stability, taste, bioavailability, etc. With the help of IDS, we can now customize the density of UtheverTM NMN bulk materials to avoid cross-contamination and decrease the loss during formulation.

The attraction of NMN is continuously growing. In a sea of fake materials, UtheverTM never compromises on quality.

Effepharm is delighted to tell you the big news. Businesswire and other newspapers also reported this. If you are interested in it, visit here